Market Cap 796.08M
Revenue (ttm) 260.21M
Net Income (ttm) -12.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4.91%
Debt to Equity Ratio 0.00
Volume 4,045,000
Avg Vol 1,485,360
Day's Range N/A - N/A
Shares Out 58.93M
Stochastic %K 15%
Beta N/A
Analysts Strong Sell
Price Target $23.18

Company Profile

Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for e...

Industry: Health Information Services
Sector: Healthcare
Phone: 888 987 8337
Address:
611 Gateway Blvd, Suite 120, South San Francisco, United States
HaynesLeverage
HaynesLeverage Mar. 10 at 9:35 AM
$OMDA microcap asymmetry setup, quiet accumulation matters a lot before the crowd arrives
0 · Reply
PROTECTORoftheREALM2
PROTECTORoftheREALM2 Mar. 9 at 7:42 PM
$OMDA after those earnings this should jump well above $16 TODAY but I also don’t mind a steady growth till $18 over the next weeks
0 · Reply
JackSch
JackSch Mar. 9 at 3:31 PM
$OMDA despicable bio shit you hold at your own responsibility.
0 · Reply
healthcareguru
healthcareguru Mar. 9 at 3:16 PM
0 · Reply
Stackdoe101
Stackdoe101 Mar. 9 at 2:43 PM
0 · Reply
ProTraderColin
ProTraderColin Mar. 9 at 2:01 PM
$OMDA nice grind
0 · Reply
buylowandwait
buylowandwait Mar. 6 at 7:38 PM
$OMDA Solid execution, and very conservative guidance. Insiders need to slow down selling as the founders sell everything when option is ready to exercise. This casts a poor image on the company future.
0 · Reply
omaia
omaia Mar. 6 at 6:33 PM
$OMDA results great, growing 50%+ breakeven. Guidance moderate, possibly only conservative. Almost halved since listing, 4x revenue breakeven cash 20%+ market cap. Chronic disease is very recurring revenue and growth.
0 · Reply
HoganHamlet
HoganHamlet Mar. 6 at 5:03 PM
$OMDA went public in June 2025. Initial consensus at the time of the IPO was ~$222M of Revenue and a $19M Adj. EBITDA loss for 2025. They delivered $260M of revenue and $6.5M of positive adj. EBITDA.
0 · Reply
stockinvestor102
stockinvestor102 Mar. 6 at 4:44 PM
Opened a starter position in $OMDA . Very impressive results.
1 · Reply
Latest News on OMDA
Omada Health, Inc. (OMDA) Q4 2025 Earnings Call Transcript

Mar 6, 2026, 1:16 AM EST - 15 days ago

Omada Health, Inc. (OMDA) Q4 2025 Earnings Call Transcript


Omda AS (CSAMF) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 6:47 AM EST - 23 days ago

Omda AS (CSAMF) Q4 2025 Earnings Call Transcript


Omada Health to Participate in J.P. Morgan Healthcare Conference

Dec 22, 2025, 9:00 AM EST - 3 months ago

Omada Health to Participate in J.P. Morgan Healthcare Conference


Omada Health: Business Is Scaling Very Healthily

Dec 4, 2025, 5:29 AM EST - 3 months ago

Omada Health: Business Is Scaling Very Healthily


Omada Health to Participate in Evercore Healthcare Conference

Nov 20, 2025, 9:05 AM EST - 4 months ago

Omada Health to Participate in Evercore Healthcare Conference


Omada Health, Inc. (OMDA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 9:26 PM EST - 4 months ago

Omada Health, Inc. (OMDA) Q3 2025 Earnings Call Transcript


Omada Health Reports Third Quarter 2025 Results

Nov 6, 2025, 4:10 PM EST - 4 months ago

Omada Health Reports Third Quarter 2025 Results


Omada Health to Participate in Upcoming Investor Conference

Aug 26, 2025, 9:00 AM EDT - 7 months ago

Omada Health to Participate in Upcoming Investor Conference


Omada Health Reports Second Quarter 2025 Results

Aug 7, 2025, 4:05 PM EDT - 8 months ago

Omada Health Reports Second Quarter 2025 Results


Omada Health: Long Growth Runway Ahead

Jul 19, 2025, 1:14 AM EDT - 8 months ago

Omada Health: Long Growth Runway Ahead


Omada Health: Helping Patients, Investors As Well?

Jun 7, 2025, 5:10 AM EDT - 10 months ago

Omada Health: Helping Patients, Investors As Well?


Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest

Jun 6, 2025, 8:21 AM EDT - 10 months ago

Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest


Omada Health Announces Pricing of Initial Public Offering

Jun 5, 2025, 8:49 PM EDT - 10 months ago

Omada Health Announces Pricing of Initial Public Offering


HaynesLeverage
HaynesLeverage Mar. 10 at 9:35 AM
$OMDA microcap asymmetry setup, quiet accumulation matters a lot before the crowd arrives
0 · Reply
PROTECTORoftheREALM2
PROTECTORoftheREALM2 Mar. 9 at 7:42 PM
$OMDA after those earnings this should jump well above $16 TODAY but I also don’t mind a steady growth till $18 over the next weeks
0 · Reply
JackSch
JackSch Mar. 9 at 3:31 PM
$OMDA despicable bio shit you hold at your own responsibility.
0 · Reply
healthcareguru
healthcareguru Mar. 9 at 3:16 PM
0 · Reply
Stackdoe101
Stackdoe101 Mar. 9 at 2:43 PM
0 · Reply
ProTraderColin
ProTraderColin Mar. 9 at 2:01 PM
$OMDA nice grind
0 · Reply
buylowandwait
buylowandwait Mar. 6 at 7:38 PM
$OMDA Solid execution, and very conservative guidance. Insiders need to slow down selling as the founders sell everything when option is ready to exercise. This casts a poor image on the company future.
0 · Reply
omaia
omaia Mar. 6 at 6:33 PM
$OMDA results great, growing 50%+ breakeven. Guidance moderate, possibly only conservative. Almost halved since listing, 4x revenue breakeven cash 20%+ market cap. Chronic disease is very recurring revenue and growth.
0 · Reply
HoganHamlet
HoganHamlet Mar. 6 at 5:03 PM
$OMDA went public in June 2025. Initial consensus at the time of the IPO was ~$222M of Revenue and a $19M Adj. EBITDA loss for 2025. They delivered $260M of revenue and $6.5M of positive adj. EBITDA.
0 · Reply
stockinvestor102
stockinvestor102 Mar. 6 at 4:44 PM
Opened a starter position in $OMDA . Very impressive results.
1 · Reply
StockMomentumLab
StockMomentumLab Mar. 6 at 3:50 PM
$OMDA just got obliterated — from +21% intraday highs down to -5% today. Q4 numbers? Flawless. Revenue up 32% YoY, gross margin holding steady at 65%, EPS crush at $0.42 vs $0.28 expected. Market reaction? Nada. Nothing. The tape doesn’t care about fundamentals — it only cares about headlines, momentum, and sentiment. This is classic “market punishes perfection”: shares are now at $18.74, still way under the multiples peers are trading. Short-term pain, but anyone paying attention knows Q4 proves the story is intact. Big setups forming if the market flips back to rational. Call-heavy OI and low float could make the next squeeze violent. $OMDA 👉Click to view @StockMomentumLab for timely updates amid the volatility.
1 · Reply
R33dh
R33dh Mar. 6 at 3:29 PM
$OMDA Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $17 to $18
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Mar. 6 at 3:14 PM
got $OMDA on radar but need H% to get low first like usual
0 · Reply
Alex1965
Alex1965 Mar. 6 at 2:55 PM
$OMDA It was the full year revenue guidance for 2026 and the valuation seems right at these levels.
1 · Reply
Alex1965
Alex1965 Mar. 6 at 2:53 PM
$OMDA LifeMD (LFMD) is reporting on Monday after market closed.
0 · Reply
Alex1965
Alex1965 Mar. 6 at 2:51 PM
$OMDA Was the results already priced in @ $13.50 ? They issued preliminary results in January. Must be the valuation is ok at these levels or the lower than expected revenue growth expected but the company in 2026, the guidance seemed weak but why ?
1 · Reply
PROTECTORoftheREALM2
PROTECTORoftheREALM2 Mar. 6 at 2:40 PM
$OMDA what the hell is happening here, from +14% in pre market to -4%
2 · Reply
lovelylee
lovelylee Mar. 6 at 2:25 PM
$GCO $IOT $JZXN $MRVL $OMDA $JZXN wants $2 real bad
0 · Reply
StockElementCorporation
StockElementCorporation Mar. 6 at 1:55 PM
Premarket movers 📈 Upside: $GCO +20% — earnings and guidance $JZXN +13% — $80M investment at $2/share $MRVL +12% — earnings $IOT +11% — earnings $OMDA +11% — earnings SWBI +11% — earnings PTRN +6.6% — earnings DOW +4.2% — analyst upgrade GWRE +3.2% — earnings PBR +2.0% — earnings Downside: NUTX -24% — earnings
0 · Reply
briefingcom
briefingcom Mar. 6 at 1:25 PM
$OMDA: Omada Health (+10.6%) beats by $0.07, beats on revs; midpoint of FY26 revenue guidance above consensus https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260305160732OMDA&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
OpenOutcrier
OpenOutcrier Mar. 6 at 1:14 PM
$OMDA (+11.7% pre) Omada reports first profitable quarter as it seizes broad GLP-1 opportunity https://ooc.bz/l/95796
0 · Reply
R33dh
R33dh Mar. 6 at 1:13 PM
$OMDA eyyyy trending! Makes sense. It’s one of the most undervalued companies
0 · Reply